<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01178918</url>
  </required_header>
  <id_info>
    <org_study_id>KOPA-H1N1-01</org_study_id>
    <nct_id>NCT01178918</nct_id>
  </id_info>
  <brief_title>Non-specific Response to H1N1 Vaccine</brief_title>
  <official_title>Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University Clinic of Pulmonary and Allergic Diseases Golnik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University Clinic of Pulmonary and Allergic Diseases Golnik</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study with recruitment of healthy volunteers from
      consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and
      Allergic Diseases, Golnik, Slovenia.

      The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1
      vaccines.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination</measure>
    <time_frame>At 3 weeks after vaccination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination</measure>
    <time_frame>At 11 weeks after vaccination.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Influenza H1N1</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers from recipients of H1N1 vaccine</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University
        Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recipients of H1N1 influenza vaccine.

          -  Healthy individuals with no signs of influenza or other infectious disease.

        Exclusion Criteria:

          -  Signs of influenza or other infectious disease in 1 month before study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Clinic of Respiratory and Allergic Diseases</name>
      <address>
        <city>Golnik</city>
        <zip>4204</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2010</study_first_submitted>
  <study_first_submitted_qc>August 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2010</study_first_posted>
  <last_update_submitted>August 9, 2010</last_update_submitted>
  <last_update_submitted_qc>August 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Head of PMO</name_title>
    <organization>The University Clinic of Pulmonary and Allergic Diseases Golnik</organization>
  </responsible_party>
  <keyword>Influenza H1N1</keyword>
  <keyword>Vaccine</keyword>
  <keyword>Adjuvant</keyword>
  <keyword>T Lymphocytes</keyword>
  <keyword>Non-specific response</keyword>
  <keyword>Interleukin-2</keyword>
  <keyword>Non-specific T cell responce</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

